QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SUPN

QT59Supernus Pharmaceuticals, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
44.38
+0.80+1.84%
OverviewShort InterestFilings
SUPNQT59Supernus Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
44.38+1.84%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
-0.51
Insider Own3.29%
Shs Outstand58.04M
Perf Week-2.57%
Market Cap2.53BForward P/E11.32EPS next Y3.92Insider Trans0.41%Shs Float-Perf Month-6.80%
Enterprise Value2.39BPEG0.89EPS next Q0.46Inst Own-Short Float-Perf Quarter-9.13%
Income-29087756.00P/S3.26EPS this Y587.58%Inst Trans-Short Ratio-Perf Half Y-8.15%
Sales776.83MP/B2.33EPS next Y57.64%ROA-1.93%Short Interest-Perf YTD-10.70%
Book/sh18.56P/C30.18EPS next 5Y29.04%ROE-2.73%52W High59.68 -25.64%Perf Year37.27%
Cash/sh6.62P/FCF30.75EPS past 3/5Y-ROIC-2.16%52W Low30.83 43.95%Perf 3Y-
Dividend Est.-EV/EBITDA46.10Sales past 3/5Y2.53% 6.70%Gross Margin89.42%Volatility2.48% 2.26%Perf 5Y-
Dividend TTM-EV/Sales3.07EPS Y/Y TTM159.85%Oper. Margin-5.37%ATR (14)1.60Perf 10Y-
Dividend Ex-Date-Quick Ratio1.72Sales Y/Y TTM17.37%Profit Margin-3.74%RSI (14)40.35Recom2.33
Dividend Gr. 3/5Y-Current Ratio1.96EPS Q/Q40.48%SMA20-2.24%Beta0.74Target Price60.00
Payout0.00%Debt/Eq0.04Sales Q/Q38.67%SMA50-7.68%Rel Volume1.68Prev Close43.58
Employees674LT Debt/Eq0.03EarningsAug 04SMA200-9.42%Avg Volume651.54KPrice44.38
IPO DateMay 01, 2012Option/ShortYes / YesEPS/Sales Surpr.110.71% 7.77%Net Debt/EBITDA-2.78Volume1,096,029Change1.84%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-25-26ReiteratedCraig-Hallum$65
Dec-19-25ReiteratedStifel NicolausHold$50 → $55
Oct-09-25UpgradePiper SandlerNeutral → Overweight$65
Sep-30-25ReiteratedCantor FitzgeraldOverweight$42 → $63
Aug-29-25ReiteratedPiper SandlerNeutral$36 → $40
Jul-29-25ReiteratedCantor FitzgeraldNeutral$42
Feb-19-25DowngradeCantor FitzgeraldOverweight → Neutral
Sep-11-24DowngradePiper SandlerOverweight → Neutral$41 → $36
May-24-24ReiteratedPiper SandlerOverweight$41
Apr-08-24ReiteratedJefferiesBuy$40
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue777719662
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A827578
Gross Profit695644584
Selling, General and Administrative Excl. Other521486336
Research and Development118106109
Other Operating Expense988957
Operating Income-41-3782
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)412-16
Net Income Before Taxes-49-4998
Income Taxes-21-1024
Consolidated Net Income-29-3974
Net Income From Continuing Operations-29-3974
Net Income-29-3974
EPS (Recurring)-0.51-0.681.34
EPS (Basic, Before Extraordinaries)-0.51-0.681.34
EPS (Diluted)-0.51-0.681.32
EBITDA5243178
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.313.87—
Gross Margin89.4589.5788.22
Operating Margin-5.28-5.1512.39
Net Margin-3.73-5.4211.18
Shares Outstanding585655
Market Capitalization2,5742,783—
Operating Lease Expense
———
Insider Trading Volume
$46.31$43.89$41.47$39.05$36.63● Close Price0.00M2.38M4.76M7.14M9.52MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Sale49.607,250359,62117,044Mar 18 12:00 AM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Option Exercise39.4014,500571,30024,294Mar 18 12:00 AM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Option Exercise38.51100,0003,851,07667,044Mar 18 12:00 AM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Sale50.3050,0002,514,88717,044Mar 18 12:00 AM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 16 '26Option Exercise33.62100,0003,362,41267,044Mar 18 12:00 AM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 16 '26Sale50.2850,0002,513,92517,044Mar 18 12:00 AM
Khattar Jack A.President, CEOMar 13 '26Sale50.3835,0001,763,124958,100Mar 16 12:00 AM
Hudson Frederick M.DirectorMar 12 '26Sale50.615,369271,72560,413Mar 16 12:00 AM
Horich William ToddSVP, Commercial OperationsMar 10 '26Sale55.004,439244,1450Mar 10 12:00 AM
Mottola FrankSVP, Chief Tech. Ops. OfficerMar 09 '26Sale53.651,62387,07418,440Mar 10 12:00 AM
Horich William ToddSVP, Commercial OperationsMar 09 '26Sale54.004,438239,6524,439Mar 10 12:00 AM
Horich William ToddSVP, Commercial OperationsMar 06 '26Option Exercise0.008,62509,991Mar 10 12:00 AM
Khattar Jack A.President, CEOMar 06 '26Option Exercise0.0077,28001,245,218Mar 10 12:00 AM
Mottola FrankSVP, Chief Tech. Ops. OfficerMar 06 '26Option Exercise0.007,500021,856Mar 10 12:00 AM
DEC TIMOTHY CSenior Vice-President & CFOMar 06 '26Option Exercise0.009,00009,682Mar 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR